ClinicalTrials.gg
Drug

Iohexol clinical trials

Also written Omnipaque.

studies test it
18
open now
3
in phase 3
2
first study started
2007

How each study uses Iohexol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Iohexol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Dec 1985 · OMNIPAQUE 140 · NDA 018956 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Iohexol
12

Brand

Omnipaque
9
Omnipaque 300
1

Studies by the year they started

18 studies that test it; most in 2020 (3)

Studies that test Iohexol, by start year
YearStudies
20071
20081
20101
20111
20141
20151
20162
20171
20203
20221
20232
20241
20252

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
4
Phase 2
2
Phase 3
2
Phase 4
3
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 14

Centre Hospitalier Universitaire de Saint Etienne (2) · NRG Oncology (1) · University Hospital, Angers (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Assistance Publique - Hôpitaux de Paris (1) · University Hospital, Tours (1) · MediBeacon (1) · University of Nebraska (1)

Often tested with

Tested in the same studies.

Carboplatin (1) · Relmapirazin (1) · Abemaciclib (1) · Metformin (1) · Dolutegravir (1) · Lidocaine (1) · Methylprednisolone (1) · Saline Solution (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Iohexol.

Studies

Open first, then newest update. How each study uses Iohexol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Given beside what is tested · 3 — Iohexol is usual care or a partner of the new treatment

Codes

What other systems call Iohexol · ClinicalTrials.gg INT007681

  • MeSH (NLM) D007472IohexolConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 4419T9MX03IOHEXOLConfirmed FDA, NLM, Wikidata
  • RxNorm 5956Confirmed FDA, Wikidata
  • Wikidata Q410683iohexolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65939IohexolOne source FDA
  • DrugBank DB01362One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.